Minimally invasive hepatopancreatobiliary surgery leads to significant cost savings and shorter recovery compared to open surgery. 1-year total expenditures were reduced by $33,255. Hospital stays were 2.6 days shorter, with a 30-day readmission rate of 29% lower (odds ratio 0.71). Surgeons should consider the benefits of minimally invasive techniques for enhanced patient outcomes and cost […]
Category: HPB & Spleen
Robotic Pancreatoduodenectomy Cuts Recovery Time
Robotic pancreatoduodenectomy (rpd) significantly accelerates postoperative recovery compared to open pancreatoduodenectomy (opd). Average recovery time was 12.1 days (rpd) versus 16.0 days (opd), a 3.9-day advantage (p<0.001). Operative time was longer for rpd (300 minutes) versus opd (270 minutes, p<0.001), but postoperative stay was shorter for rpd (13 days). Surgeons in high-volume centers can confidently […]
Robotic Liver Resection is Safe and Feasible for Selected Patients
Early experience with the da Vinci SP system shows promising outcomes for robotic liver resections. 20 patients studied; median age 74 years, tumor size 1.9 cm. No conversions or intraoperative transfusions; only one major complication (duodenal ulcer bleeding). Zero instances of bile leakage, posthepatectomy liver failure, or 30-day mortality. This technique may be beneficial in […]
Improved Decision-Making for Pancreatic Cysts
Endoscopic ultrasound (EUS) significantly enhances diagnosis for pancreatic cystic neoplasms when MRI results are inconclusive. EUS detected morphologic high-risk features in 24% of cases, while MRI detected 28%, with 26% discordance between the two. In surgical patients, using EUS after normal MRI increased specificity by 14%, reaching 38% when combined with fine needle aspiration (FNA). […]
Preoperative Liver Function Score Predicts Outcomes in Cancer Resection
High baseline liver function scores predict worse long-term survival in biliary tract cancer surgery. In a study of 616 patients, high APRI+ALBI scores correlated with median overall survival of 39.8 months vs. 62.9 months for low scores. The high score group also faced more complications and a 90-day mortality rate linked to major hepatectomy and […]
Extended Liver Resection in Locally Advanced Cholangiocarcinoma
Extended liver resection for locally advanced intrahepatic cholangiocarcinoma (LAICC) shows promising outcomes, challenging previous doubts about surgical futility. 90-day mortality is low at 5% with an overall morbidity of 56%. Median overall survival is 58 months; recurrence-free survival is 23 months. Nodal status is crucial for prognosis—patients with nodal involvement had significantly lower survival rates. […]
Enhanced Imaging Boosts Liver Cancer Detection
Adding indocyanine green fluorescence imaging to intraoperative ultrasound significantly improves the detection of liver cancer lesions, a crucial advancement for surgical outcomes. Sensitivity increases dramatically to 99.78% compared to just 86.8% with ultrasound alone. The combination showed a 15.07 odds ratio over ultrasound alone, indicating a substantial advantage in lesion detection. This technique could reduce […]
Learning Curve Impact on Robotic Left-Sided Pancreatectomy
Robotic left-sided pancreatectomy is safe during the learning curve, challenging the notion of increased risk during early cases. Major morbidity rates were similar between competency (14.5%) and proficiency phases (14.0%), p = .981. Predictors of major morbidity included male sex, preoperative pancreatitis, and multivisceral resection. Surgeons should remain vigilant about case complexity as proficiency increases. […]
Postoperative Exercise Training Reduces Complications in CRLM
Postoperative exercise can safely enhance recovery for patients with colorectal liver metastases, improving outcomes without increasing adverse events. Serious adverse events were similar in both exercise and control groups. Non-serious adverse events were significantly lower in the exercise group, with a reduction of nearly 5 events. Patients in the exercise group started chemotherapy earlier (25 […]
New Insights on Pancreatic Cancer Post-Surgery Outcomes
A study reveals that pancreatic ductal adenocarcinoma morphology predicts survival after surgery, impacting patient selection and prognosis. 400 patients analyzed, identifying 10 morphologic subtypes; gland-forming was most common (41.8%). Heterogeneous tumors (38.3% of cases) are linked to worse outcomes, including higher nodal metastasis and lower survival rates (median 30.1 months). Consider integrating morphologic subtype and […]
